SeekingAlpha  Aug 1  Comment 
Cambrex. (NYSE:CBM) Q2 2014 Earnings Call August 01, 2014 8:30 am ET Executives Gregory P. Sargen - Chief Financial Officer, Principal Accounting Officer and Executive Vice President Steven M. Klosk - Chief Executive Officer,...
Benzinga  Aug 1  Comment 
Expedia (NASDAQ: EXPE) shares reached a new 52-week high of $84.13 after the company reported upbeat results for the second quarter. Analysts at Raymond James upgraded Expedia from Market Perform to Outperform. Intervest Bancshares (NASDAQ:...
SeekingAlpha  May 2  Comment 
Cambrex Corporation (CBM) Q1 2014 Earnings Conference Call May 2, 2014 03:30 ET Executives Greg Sargen – EVP & CFO Steve Klosk – President & CEO Analysts Daniel Rizzo – Sidoti & Company Dmitry Silversteyn –...
SeekingAlpha  Feb 11  Comment 
Cambrex. (CBM) Q4 2013 Earnings Call February 11, 2014 8:30 am ET Executives Gregory P. Sargen - Chief Financial Officer, Principal Accounting Officer and Executive Vice President Steven M. Klosk - Chief Executive Officer, President...
Forbes  Feb 7  Comment 
Investors eyeing a purchase of Cambrex Corp (NYSE: CBM) stock, but tentative about paying the going market price of $21.17/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put...
StreetInsider.com  Jan 28  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Upgrades/First+Analysis+Upgrades+Cambrex+Corporation+%28CBM%29+to+Overweight/9093422.html for the full story.
StreetInsider.com  Nov 1  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Cambrex+Corp.+%28CBM%29+Misses+Q3+EPS+by+1c%2C+Sees+Slightly+Higher+FY+Sales%2C+EBITDA/8835208.html for the full story.
Jutia Group  Oct 29  Comment 
[at noodls] - The Dow Chemical Company (NYSE: DOW) and Cambrex (NYSE: CBM) celebrated the completion of the new operational facility for Dow's Hydroxypropyl Methylcellulose Acetate Succinate (HPMCAS) for Drug Solubility ... Read more on this. The...

You may also be interested in articles related to Cambrex (CBM):


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki